AstraZeneca PLC figure parmi les principaux groupes pharmaceutiques mondiaux. Le CA par source de revenus se répartit comme suit :
- ventes de produits (96,9%). Le CA par domaine thérapeutique se ventile entre oncologie (34%), maladies cardio-vasculaires, rénales et métaboliques (21,4%), maladies respiratoires et auto-immunes (13,4%) et autres (31,2% ; maladies inflammatoires, maladies neurologiques, maladies gastro-intestinales et maladies infectieuses) ;
- revenus de collaboration (3,1%).
La répartition géographique du CA est la suivante : Royaume Uni (7%), Europe (20,1%), Amérique (44,2%) et Afrique-Asie-Australie (28,7%).
Nombre d'employés : 83 500 personnes.
2021 2022 Delta Oncology 9 487.36 34.9% 11 877.90 33% +25.2%
Cardiovascular, Renal and Metabolism 5 831.44 21.4% 7 459.12 20.7% +27.91%
Rare Disease 2 232.23 8.2% 5 725.86 15.9% +156.51%
Respiratory and Immunology 4 387.39 16.1% 4 680.22 13% +6.67%
Vaccines and Immune Therapies - - 3 844.84 10.7% -
Other Medicines 1 721.07 6.3% 1 319.23 3.7% -23.35%
Collaboration 636.95 2.3% 1 098.41 3.1% +72.45%
GBP en Millions
2021 2022 Delta United States 8 759.52 32.2% 14 026.90 39% +60.13%
China 4 364.13 16% 4 662.36 12.9% +6.83%
Japan 2 468.55 9.1% 3 235.97 9% +31.09%
United Kingdom 2 359.48 8.7% 2 530.48 7% +7.25%
Other Rest of Europe 1 417.14 5.2% 2 196.82 6.1% +55.02%
Other Asia, Africa and Australasia 1 729.80 6.4% 1 953.27 5.4% +12.92%
Germany 1 080.49 4% 1 544.11 4.3% +42.91%
Sweden 1 688.35 6.2% 1 397.16 3.9% -17.25%
Other Americas 874.72 3.2% 953.90 2.6% +9.05%
Canada 561.33 2.1% 946.60 2.6% +68.63%
France 665.31 2.4% 898.70 2.5% +35.08%
Spain 420.27 1.5% 599.13 1.7% +42.56%
Italy 419.54 1.5% 596.70 1.7% +42.23%
Australia 397.73 1.5% 463.56 1.3% +16.55%
GBP en Millions
Vote Nombre Flottant Autocontrôle Flottant Total
Action A
1
1 549 857 245
1 494 650 964
96.4%
0
0.0%
96.4%
Actionnaires AstraZeneca PLC (GB0009895292) AstraZeneca PLC (US) AstraZeneca PLC (BRA1ZNBDR003)
Nom Actions % BlackRock Investment Management (UK) Ltd. 75 472 151
4,87% Wellington Management Co. LLP 64 146 178
4,14% The Vanguard Group, Inc. 53 642 000
3,46% Investor AB (Investment Company) 51 587 810
3,33% Capital Research & Management Co. (World Investors) 35 778 775
2,31% BlackRock Fund Advisors 29 152 681
1,88% BlackRock Advisors (UK) Ltd. 21 766 628
1,40% GQG Partners LLC 17 826 000
1,15% BlackRock Advisors LLC 15 470 125
1,00% SSgA Funds Management, Inc. 15 382 327
0,99%
Nom Actions % Investor AB (Investment Company) 190 171 620
6,14% T. Rowe Price Associates, Inc. (Investment Management) 58 817 969
1,90% Wellington Management Co. LLP 52 654 502
1,70% PRIMECAP Management Co. 45 389 857
1,46% Capital Research & Management Co. (International Investors) 38 128 710
1,23% GQG Partners LLC 21 545 387
0,70% Jennison Associates LLC 16 190 155
0,52% Fidelity Management & Research Co. LLC 14 993 477
0,48% Capital Research & Management Co. 14 965 800
0,48% Regents of the University of California 10 965 024
0,35%
Nom Actions % Caixa DTVM SA 349 663
0,0038%
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Nasdaq 100, NASDAQ OMX Nordic 120, OMX Nordic 40, OMX Stockholm 30, Stoxx Europe 50, STOXX Europe 600, Stoxx Global 200, Stoxx UK 50
- Code Bloomberg :
AZN:LN
- Code Reuters :
AZN.L
- Code Datastream :
Point sur les Notations Crédit
Secteur Pharmacies - Autres
Connexions : AstraZeneca PLC